Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA

Warren, Luigi, Manos, Philip D., Ahfeldt, Tim, Loh, Yuin-Han, Li, Hu, Lau, Frank, Ebina, Wataru, Mandal, Pankaj K. +8 more·2010·Cell Stem Cell

Cited by (1,006)

Items 401–500 of 1,006

  1. An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications
    Manash P. Borgohain, Krishna Kumar Haridhasapavalan, Chandrima Dey, Poulomi Adhikari, Rajkumar P. Thummer · 2018 · Stem Cell Reviews and Reports
  2. Label-free analysis of mRNA capping efficiency using RNase H probes and LC-MS
    Beverly, Michael, Dell, Amy, Parmar, Parul, Houghton, Leslie · 2016 · Analytical and Bioanalytical Chemistry
  3. Materials control of the epigenetics underlying cell plasticity
    Stephanie R. Nemec, Kristopher Alan Kilian · 2020 · Nature Reviews Materials
  4. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease
    Thomas Doetschman, Teodora G. Georgieva · 2017 · Circulation Research
  5. Engineering a living cardiac pump on a chip using high-precision fabrication
    Michas, Christos, Karakan, M. Çağatay, Nautiyal, Pranjal, Seidman, Jonathan G., Seidman, Christine E., Agarwal, Arvind, Ekinci, Kamil, Eyckmans, Jeroen, White, Alice E., Chen, Christopher S. · 2022 · Science Advances
  6. Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells
    Ivana Grabundžija, Jichang Wang, Attila Sebe, Zsuzsanna Erdei, Robert Kajdi, Anantharam Devaraj, Doris Steinemann, Károly Szuhai, Ulrike Stein, Tobias Cantz et al. · 2012 · Nucleic Acids Research
  7. Human pluripotent stem cell–derived models and drug screening in CNS precision medicine
    M. Catarina Silva, Stephen J. Haggarty · 2019 · Annals of the New York Academy of Sciences
  8. Jak/Stat3 Signaling Promotes Somatic Cell Reprogramming by Epigenetic Regulation
    Yong Tang, Yan Luo, Zongliang Jiang, Yinghong Ma, Chih‐Jen Lin, Chul Geun Kim, Mark G. Carter, Tomokazu Amano, Joonghong Park, Sharon L. Kish et al. · 2012 · Stem Cells
  9. Induced pluripotent stem cells for modelling human diseases
    Juli Unternaehrer, George Q. Daley · 2011 · Philosophical Transactions of the Royal Society B Biological Sciences
  10. Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins
    Tim Beißert, Lars Koste, Mario Perković, Kerstin C. Walzer, Stephanie Erbar, Abderraouf Selmi, Mustafa Diken, Sebastian Kreiter, Özlem Türeci, Uğur Şahin · 2017 · Human Gene Therapy
  11. A critical look: Challenges in differentiating human pluripotent stem cells into desired cell types and organoids
    Jonas L. Fowler, Lay Teng Ang, Kyle M. Loh · 2019 · Wiley Interdisciplinary Reviews Developmental Biology
  12. Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives
    M. M. Rahman, Mohammad Rezaul Islam, Mohammad Touhidul Islam, M. Harun-Or-Rashid, Mahfuzul Islam, S. Abdullah, M. B. Uddin, Sumit Das, Mohammad Saidur Rahaman, Muniruddin Ahmed et al. · 2022 · Biology
  13. mRNA vaccines: the most recent clinical applications of synthetic mRNA
    Suji Kwon, Minseon Kwon, Seongeun Im, Kyuri Lee, Hyukjin Lee · 2022 · Archives of Pharmacal Research
  14. Genetic Correction of Induced Pluripotent Stem Cells From a Deaf Patient With MYO7A Mutation Results in Morphologic and Functional Recovery of the Derived Hair Cell-Like Cells
    Zi-Hua Tang, Jia-Rong Chen, Jing Zheng, Haosong Shi, Jie Ding, Xiaodan Qian, Cui Zhang, Jianling Chen, Cui-Cui Wang, Liang Li et al. · 2016 · Stem Cells Translational Medicine
  15. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Vimal Kishor Singh, Neeraj Kumar, Manisha Kalsan, Abhishek Saini, Ramesh Chandra · 2015 · PubMed
  16. Bone Tissue Engineering Using Human Cells: A Comprehensive Review on Recent Trends, Current Prospects, and Recommendations
    Saeid Kargozar, Masoud Mozafari, Sepideh Hamzehlou, Peiman Brouki Milan, Hae‐Won Kim, Francesco Baino · 2019 · Applied Sciences
  17. Stem Cell Models for Drug Discovery and Toxicology Studies
    Wenwei Liu, Yaguang Deng, Ying Liu, Wenrong Gong, Wenbin Deng · 2013 · Journal of Biochemical and Molecular Toxicology
  18. Developmental and Regenerative Biology of Multipotent Cardiovascular Progenitor Cells
    Anthony C. Sturzu, Sean M. Wu · 2011 · Circulation Research
  19. Life in the Fast Lane: Mammalian Disease Models in the Genomics Era
    Lukas E. Dow, Scott W. Lowe · 2012 · Cell
  20. Application of Rho-associated protein kinase (ROCK) inhibitor to human pluripotent stem cells
    Hiroshi Kurosawa · 2012 · Journal of Bioscience and Bioengineering
  21. Anti-Aging Strategies Based on Cellular Reprogramming
    Alejandro Ocampo, Pradeep Reddy, Juan Carlos Izpisúa Belmonte · 2016 · Trends in Molecular Medicine
  22. Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo
    Markus C. Doeser, Hans Robert Schöler, Guangming Wu · 2018 · Stem Cells
  23. Tissue engineering: current status and future perspectives
    Prafulla Chandra, S. Soker, A. Atala · 2020 · Principles of Tissue Engineering
  24. Hematopoietic stem cell engineering at a crossroads
    Isabelle Rivière, Cynthia E. Dunbar, Michel Sadelain · 2011 · Blood
  25. AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized Models
    Vidyullatha Vasireddy, Jason A. Mills, Rajashekhar Gaddameedi, Etiena Basner‐Tschakarjan, Monika Köhnke, Aaron D. Black, Kirill A. Alexandrov, Shangzhen Zhou, Albert M. Maguire, Daniel C. Chung et al. · 2013 · PLoS ONE
  26. The cell cycle and pluripotency
    Christopher J. Hindley, Anna Philpott · 2013 · Biochemical Journal
  27. Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges
    Heidrun Steinle, Andreas Behring, Christian Schlensak, Hans Peter Wendel, Meltem Avci‐Adali · 2016 · Stem Cells
  28. Immunological aspects of RPE cell transplantation
    Sugita, Sunao, Mandai, Michiko, Kamao, Hiroyuki, Takahashi, Masayo · 2021 · Progress in Retinal and Eye Research
  29. The biology of aging: 1985–2010 and beyond
    George M. Martin · 2011 · The FASEB Journal
  30. Characterizing exogenous mRNA delivery, trafficking, cytoplasmic release and RNA–protein correlations at the level of single cells
    Jonathan L. Kirschman, Sushma M. Bhosle, Daryll A. Vanover, Emmeline L. Blanchard, Kristin H. Loomis, Chiara Zurla, Kathryn A. Murray, Blaine C. Lam, Philip J. Santangelo · 2017 · Nucleic Acids Research
  31. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo
    Johanna Walther, Deja Porenta, Danny Wilbie, Cornelis W. Seinen, Naomi Benne, Qiangbing Yang, Olivier G. de Jong, Zhiyong Lei, Enrico Mastrobattista · 2024 · European Journal of Pharmaceutics and Biopharmaceutics
  32. Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes
    Anna-Karin M. Sjogren, Maria Liljevald, Björn Glinghammar, Johanna Sagemark, Xueqing Li, Anna Jonebring, Ian A. Cotgreave, Gabriella Brolén, Tommy B. Andersson · 2014 · Archives of Toxicology
  33. Identification of Transcription Factors for Lineage-Specific ESC Differentiation
    Kohei Yamamizu, Yulan Piao, Alexei A. Sharov, Veronika Zsiros, Hong Yu, Kazu Nakazawa, David Schlessinger, Minoru S.H. Ko · 2013 · Stem Cell Reports
  34. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients
    Limor Zwi‐Dantsis, Irit Huber, Manhal Habib, Aaron Winterstern, Amira Gepstein, Gil Arbel, Lior Gepstein · 2012 · European Heart Journal
  35. Pluripotent Stem Cell–Based Cancer Therapy: Promise and Challenges
    Saul J. Sharkis, Richard Julian Jones, Curt I. Civin, Yoon-Young Jang · 2012 · Science Translational Medicine
  36. Calcium signalling of human pluripotent stem cell-derived cardiomyocytes
    Li, Sen, Chen, Gaopeng, Li, Ronald A. · 2013 · The Journal of Physiology
  37. Viral and Synthetic RNA Vector Technologies and Applications
    Schott, Juliane W, Morgan, Michael, Galla, Melanie, Schambach, Axel · 2016 · Molecular Therapy
  38. Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors
    Hui Zhang, Yu Ma, Junjie Gu, Bing Liao, Jiwen Li, Jiemin Wong, Ying Jin · 2012 · Biomaterials
  39. Reversible 2′-OH acylation enhances RNA stability
    Linglan Fang, Lu Xiao, Yong Woong Jun, Yoshiyuki Onishi, Eric T. Kool · 2023 · Nature Chemistry
  40. A novel platform to enable the high-throughput derivation and characterization of feeder-free human iPSCs
    Bahram Bob Valamehr, Ramzey Abujarour, Megan Robinson, Thuy My Le, David Robbins, Daniel D. Shoemaker, Peter Flynn · 2012 · Scientific Reports
  41. Potential Therapeutic Applications of Rna Cap Analogs
    Marcin Ziemniak, Malwina Strenkowska, Joanna Kowalska, Jacek Jemielity · 2013 · Future Medicinal Chemistry
  42. Efficient Reprogramming of Human Fibroblasts and Blood-Derived Endothelial Progenitor Cells Using Nonmodified RNA for Reprogramming and Immune Evasion
    Marco A. Poleganov, Sarah Eminli, Tim Beißert, Stephanie Herz, Jung-Il Moon, Johanna E. Goldmann, Arianne Beyer, Rosario Heck, Isabell Burkhart, Diana Barea Roldán et al. · 2015 · Human Gene Therapy
  43. Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells
    Izumi Horikawa, Kyeyoon Park, Kazunobu Isogaya, Yukiharu Hiyoshi, Han Li, Katsuhiro Anami, Ana I. Robles, Abdul M Mondal, Kaori Fujita, Manuel Serrano et al. · 2017 · Cell Death and Differentiation
  44. Concise Review: Assessing the Genome Integrity of Human Induced Pluripotent Stem Cells: What Quality Control Metrics?
    Assou, Said, Bouckenheimer, Julien, De Vos, John · 2018 · Stem Cells
  45. Reprogramming with Small Molecules instead of Exogenous Transcription Factors
    Tongxiang Lin, Shouhai Wu · 2015 · Stem Cells International
  46. mRNA – A game changer in regenerative medicine, cell-based therapy and reprogramming strategies
    Oleksandra Chabanovska, Anne-Marie Galow, Robert David, Heiko Lemcke · 2021 · Advanced Drug Delivery Reviews
  47. p53 directs leader cell behavior, migration, and clearance during epithelial repair
    Kasia Kozyrska, Giulia Pilia, Medhavi Vishwakarma, Laura Wagstaff, Maja Goschorska, Silvia Cirillo, Saad Mohamad, Kelli Gallacher, Rafael E. Carazo Salas, Eugenia Piddini · 2022 · Science
  48. Identification of Oct4-activating compounds that enhance reprogramming efficiency
    Wendong Li, Erpo Tian, Zhaoxia Chen, Guoqiang Sun, Ye Peng, Su Jing Yang, Dave Lu, Jun Xie, Thach‐Vu Ho, Walter M. K. Tsark et al. · 2012 · Proceedings of the National Academy of Sciences
  49. A self-setting iPSMSC-alginate-calcium phosphate paste for bone tissue engineering
    Ping Wang, Yang Song, Michael D. Weir, Jinyu Sun, Liang Zhao, Carl G. Simon, Hockin H.K. Xu · 2015 · Dental Materials
  50. Induced Pluripotent Stem Cells for Traumatic Spinal Cord Injury
    M. Khazaei, C. Ahuja, M. Fehlings · 2017 · Front. Cell Dev. Biol.
  51. Stem cell‐derived hepatocytes as a predictive model for drug‐induced liver injury: are we there yet?
    Richard Kia, Rowena L. C. Sison-Young, James A. Heslop, Neil R. Kitteringham, Neil A. Hanley, JOHN S. MILLS, B. Kevin Park, Christopher E. Goldring · 2012 · British Journal of Clinical Pharmacology
  52. Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement
    Stephen T. Bartlett, James F. Markmann, Paul Johnson, Olle Korsgren, Bernhard J. Hering, David W. Scharp, Thomas W. H. Kay, Jonathan S. Bromberg, Jon S. Odorico, Gordon C. Weir et al. · 2016 · Transplantation
  53. Localization of transcripts, translation, and degradation for spatiotemporal sarcomere maintenance
    Yair E. Lewis, Anner Moskovitz, Michael Mutlak, Joerg Heineke, Lilac H. Caspi, Izhak Kehat · 2018 · Journal of Molecular and Cellular Cardiology
  54. The use of small molecules in somatic-cell reprogramming
    Alexander Joel Federation, James E. Bradner, Alexander Meissner · 2013 · Trends in Cell Biology
  55. Lonely death dance of human pluripotent stem cells: ROCKing between metastable cell states
    Masatoshi Ohgushi, Yoshiki Sasai · 2011 · Trends in Cell Biology
  56. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells
    Ulf Tiemann, M. Sgodda, Eva Warlich, M. Ballmaier, H. Schöler, A. Schambach, T. Cantz · 2011 · Cytometry Part A
  57. The pluripotency factor LIN28 in monkey and human testes: a marker for spermatogonial stem cells?
    Nelia Aeckerle, Katja Eildermann, Charis Drummer, Jens Ehmcke, Stefan Schweyer, Alexander Lerchl, Martin Bergmann, Sabine Kliesch, Joerg Gromoll, Stefan Schlatt et al. · 2012 · Molecular Human Reproduction
  58. iPS cell technologies and their prospect for bone regeneration and disease modeling: A mini review
    Mária Csöbönyeiová, Štefan Polák, Radoslav Zamborský, Ľuboš Danišovič · 2017 · Journal of Advanced Research
  59. Comparative performance analysis of human iPSC-derived and primary neural progenitor cells (NPC) grown as neurospheres in vitro
    Maxi Hofrichter, Laura Nimtz, Julia Tigges, Yaschar Kabiri, Friederike Schröter, Brigitte Royer‐Pokora, Barbara Hildebrandt, Martin R. Schmuck, Alexey Epanchintsev, Stephan Theiss et al. · 2017 · Stem Cell Research
  60. Comparative Analysis of Targeted Differentiation of Human Induced Pluripotent Stem Cells (hiPSCs) and Human Embryonic Stem Cells Reveals Variability Associated With Incomplete Transgene Silencing in Retrovirally Derived hiPSC Lines
    Sanna Toivonen, Marisa Ojala, Anu Hyysalo, Tanja Ilmarinen, Kristiina M Rajala, Mari Pekkanen-Mattila, Riikka Äänismaa, Karolina Lundin, Jaan Palgi, Jere Weltner et al. · 2013 · Stem Cells Translational Medicine
  61. mRNA Transfection-Induced Activation of Primary Human Monocytes and Macrophages: Dependence on Carrier System and Nucleotide Modification
    Hanieh Moradian, Toralf Roch, Andreas Lendlein, Manfred Gossen · 2020 · Scientific Reports
  62. Regulatory considerations for developing a phase I investigational new drug application for autologous induced pluripotent stem cells-based therapy product
    Balendu Shekhar Jha, Mitra Farnoodian, Kapil Bharti · 2020 · Stem Cells Translational Medicine
  63. A noncoding single-nucleotide polymorphism at 8q24 drives IDH1 -mutant glioma formation
    Connor Yanchus, Kristen L. Drucker, Thomas M. Kollmeyer, Ricky Tsai, Warren Winick‐Ng, Minggao Liang, Ahmad Malik, Judy Pawling, Silvana B. De Lorenzo, Asma Ali et al. · 2022 · Science
  64. Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond
    Britta Vallazza, Sebastian Petri, Marco A. Poleganov, Florian Eberle, Andreas N. Kuhn, Uğur Şahin · 2015 · Wiley Interdisciplinary Reviews - RNA
  65. Systematic Review of Induced Pluripotent Stem Cell Technology as a Potential Clinical Therapy for Spinal Cord Injury
    Anne S. Kramer, Alan R. Harvey, Giles W. Plant, Stuart I. Hodgetts · 2012 · Cell Transplantation
  66. Generation of Progesterone-Responsive Endometrial Stromal Fibroblasts from Human Induced Pluripotent Stem Cells: Role of the WNT/CTNNB1 Pathway
    Kaoru Miyazaki, Matthew T. Dyson, John Sayler Coon, Yuichi Furukawa, Bahar D. Yilmaz, Tetsuo Maruyama, Serdar Ekrem Bulun · 2018 · Stem Cell Reports
  67. Combined negative effect of donor age and time in culture on the reprogramming efficiency into induced pluripotent stem cells
    Ras Trokovic, Jere Weltner, Parinya Noisa, Taneli Raivio, Timo Otonkoski · 2015 · Stem Cell Research
  68. Improved translation efficiency of therapeutic mRNA
    Zarghampoor, Farzaneh, Azarpira, Negar, Khatami, Saeed Reza, Behzad-Behbahani, Abbas, Foroughmand, Ali Mohammad · 2019 · Gene
  69. Integration-Free iPS Cells Engineered Using Human Artificial Chromosome Vectors
    M. Hiratsuka, Narumi Uno, Kana Ueda, Hajime Kurosaki, Natsuko Imaoka, Kanako Kazuki, E. Ueno, Yutaro Akakura, M. Katoh, M. Osaki et al. · 2011 · PLoS ONE
  70. An AAVS1-Targeted Minigene Platform for Correction of iPSCs From All Five Types of Chronic Granulomatous Disease
    Randall K. Merling, Colin L. Sweeney, Jessica Chu, Aaron Bodansky, Uimook Choi, Debra Long Priel, Douglas Byron Kuhns, Hongmei Wang, Sam Vasilevsky, Suk See De Ravin et al. · 2014 · Molecular Therapy
  71. Human NK cell deficiency as a result of biallelic mutations in MCM10
    Emily Margaret Mace, Silke Paust, Matilde Immacolata Conte, Ryan M. Baxley, Megan Schmit, Sagar L. Patil, Nicole C. Guilz, Malini Mukherjee, Ashley E. Pezzi, Jolanta Chmielowiec et al. · 2020 · Journal of Clinical Investigation
  72. Generation of pluripotent stem cells without the use of genetic material
    Akon Higuchi, Qing‐Dong Ling, Suresh S. Kumar, Murugan A. Munusamy, Abdullah A. Alarfaj, Yung Chang, Shih-Hsuan Kao, Ke-Chen Lin, Han-Chow Wang, Akihiro Umezawa · 2014 · Laboratory Investigation
  73. Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain
    Thorold W. Theunissen, Yael Costa, Aliaksandra Radzisheuskaya, Anouk L. van Oosten, Fabrice Lavial, Bertrand Pain, L. Filipe C. Castro, José Silva · 2011 · Development
  74. mRNA-based therapeutics–Advances and perspectives
    Olga V. Sergeeva, Victor Koteliansky, Timofei S. Zatsepin · 2016 · Biochemistry (Moscow)
  75. Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector
    Eirini P. Papapetrou, Michel Sadelain · 2011 · Nature Protocols
  76. Using human induced pluripotent stem cells to treat retinal disease
    Shyamanga Borooah, M. Joseph Phillips, Bilada Bilican, Alan F. Wright, I. Wilmut, Siddharthan Chandran, David M. Gamm, Bal Dhillon · 2013 · Progress in Retinal and Eye Research
  77. May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells
    Nicholas Brookhouser, Sreedevi Raman, Christopher Potts, David A. Brafman · 2017 · Cells
  78. Master regulators of skeletal muscle lineage development and pluripotent stem cells differentiation
    Joana Esteves de Lima, Frédéric Relaix · 2021 · Cell Regeneration
  79. Concise Review: Pancreas Regeneration: Recent Advances and Perspectives
    Philippe Antoine Lysy, Gordon C. Weir, Susan Bonner‐Weir · 2012 · Stem Cells Translational Medicine
  80. Human adipose-derived stem cells enriched with VEGF-modified mRNA promote angiogenesis and long-term graft survival in a fat graft transplantation model
    Fei Yu, Nevin Witman, Dan Yan, Siyi Zhang, Meng Zhou, Yan Yan, Qinke Yao, Feixue Ding, Bingqian Yan, Huijing Wang et al. · 2020 · Stem Cell Research & Therapy
  81. Human Pluripotent Stem Cells-Based Therapies for Neurodegenerative Diseases: Current Status and Challenges
    E. Ford, Jodie Pearlman, T. Ruan, John Manion, Matthew A. Waller, G. Neely, L. Caron · 2020 · Cells
  82. The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
    Zhongfeng Ye, Joseph Harmon, Wei Ni, Yamin Li, Douglas Wich, Qiaobing Xu · 2023 · ACS Nano
  83. Toward stem cell-based phenotypic screens for neurodegenerative diseases
    Vikram Khurana, Daniel F. Tardiff, Chee Yeun Chung, Susan Lee Lindquist · 2015 · Nature Reviews Neurology
  84. Molecular Insights into Reprogramming-Initiation Events Mediated by the OSKM Gene Regulatory Network
    Nancy Mah, Ying Wang, Mei-Chih Liao, Alessandro Prigione, Justyna Józefczuk, Björn Lichtner, Katharina Wolfrum, Manuela Haltmeier, Max Flöttmann, Martin H. Schaefer et al. · 2011 · PLoS ONE
  85. Stem cell-based regenerative opportunities for the liver: State of the art and beyond
    Eleftheria Tsolaki · 2015 · World Journal of Gastroenterology
  86. Methods of induced pluripotent stem cells for clinical application
    Tomohisa Seki · 2015 · World Journal of Stem Cells
  87. Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells
    Brooke A. DeRosa, Jessica M. Van Baaren, Gaurav K. Dubey, Joycelyn M. Lee, Michael L. Cuccaro, Jeffery M. Vance, Margaret Ann Pericak‐Vance, Derek Michael Dykxhoorn · 2012 · Neuroscience Letters
  88. Specimen Collection for Induced Pluripotent Stem Cell Research: Harmonizing the Approach to Informed Consent
    Justin Lowenthal, S. Lipnick, Mahendra S. Rao, S. Hull · 2012 · Stem Cells Translational Medicine
  89. Derivation of Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
    Kamileh Narsinh, Kazim H Narsinh, Joseph C. Wu · 2011 · Circulation Research
  90. A Broad Overview and Review of CRISPR-Cas Technology and Stem Cells
    Simon N. Waddington, Riccardo Privolizzi, Rajvinder Karda, Helen C. O’Neill · 2016 · Current Stem Cell Reports
  91. Reprogramming of human fibroblasts into multipotent cells with a single ECM proteoglycan, fibromodulin
    Zhong Sheng Zheng, Jian Jia, Xinli Zhang, Janette N. Zara, Wei Yin, Michael Chiang, Yi Liu, Joyce Wang, Shen Pang, Kang Ting et al. · 2012 · Biomaterials
  92. From “ES-like” cells to induced pluripotent stem cells: A historical perspective in domestic animals
    Sehwon Koh, Jorge A. Piedrahita · 2013 · Theriogenology
  93. Endogenous WNT Signaling Regulates hPSC-Derived Neural Progenitor Cell Heterogeneity and Specifies Their Regional Identity
    Noel Moya, Josh Cutts, Terry Gaasterland, Karl Willert, David A. Brafman · 2014 · Stem Cell Reports
  94. Spinal cord injuries: how could cell therapy help?
    Anna Badner, Ahad M. Siddiqui, Michael George Fehlings · 2017 · Expert Opinion on Biological Therapy
  95. The Differentiation Stage of Transplanted Stem Cells Modulates Nerve Regeneration
    Ching-Wen Huang, Wen‐Chin Huang, Xuefeng Qiu, Flavia Fernandes Ferreira da Silva, Aijun Wang, Shyam A. Patel, Leon J. Nesti, Mu-ming Poo, Song Li · 2017 · Scientific Reports
  96. Induced pluripotent stem cells throughout the animal kingdom: Availability and applications
    Laís Vicari de Figueirêdo Pessôa, Fabiana Fernandes Bressan, Kristine Freude · 2019 · World Journal of Stem Cells
  97. Differentiation of RPE cells from integration-free iPS cells and their cell biological characterization
    Hazim, Roni A., Karumbayaram, Saravanan, Jiang, Mei, Dimashkie, Anupama, Lopes, Vanda S., Li, Douran, Burgess, Barry L., Vijayaraj, Preethi, Alva-Ornelas, Jackelyn A., Zack, Jerome A. et al. · 2017 · Stem Cell Research & Therapy
  98. A Systematic Evaluation of Integration Free Reprogramming Methods for Deriving Clinically Relevant Patient Specific Induced Pluripotent Stem (iPS) Cells
    Pollyanna Agnes Goh, Sara Caxaria, Catharina Casper, Cecilia Rosales, Thomas T. Warner, Peter J. Coffey, Amit Chunilal Nathwani · 2013 · PLoS ONE
  99. Perspectives on RNA Vaccine Candidates for COVID-19
    Pobitra Borah, Pran Kishore Deb, Nizar A. Al‐Shar’i, Lina A. Dahabiyeh, Katharigatta Narayanaswamy Venugopala, Vinayak Singh, Pottathil Shinu, Snawar Hussain, Satyendra Deka, Balakumar Chandrasekaran et al. · 2021 · Frontiers in Molecular Biosciences
  100. The Challenges to Advancing Induced Pluripotent Stem Cell-Dependent Cell Replacement Therapy
    Alan B. Moy, Anant M. Kamath, Sara Ternes, Jay Kamath · 2023 · Medical Research Archives